Literature DB >> 33776989

Immunological Hallmarks of Inflammatory Status in Vaso-Occlusive Crisis of Sickle Cell Anemia Patients.

Alexander Leonardo Silva-Junior1,2, Nadja Pinto Garcia2, Evilázio Cunha Cardoso1,2, Stephanny Dias2, Andrea Monteiro Tarragô1,2,3, Nelson Abrahim Fraiji1,2, Matheus Souza Gomes4, Laurence Rodrigues Amaral4, Andréa Teixeira-Carvalho1,5, Olindo Assis Martins-Filho1,5, Erich Vinicius De Paula1,6, Allyson Guimarães Costa1,2,3,7,8,9, Adriana Malheiro1,2,3,7.   

Abstract

Sickle Cell Anemia (SCA) is the most common genetic disorder around the world. The mutation in the β-globin gene is responsible for a higher hemolysis rate, with further involvement of immunological molecules, especially cytokines, chemokines, growth factors, and anaphylatoxins. These molecules are responsible for inducing and attracting immune cells into circulation, thus contributing to increases in leukocytes and other pro-inflammatory mediators, and can culminate in a vaso-occlusive crisis (VOC). This study aimed to characterize the levels of these molecules in SCA patients in different clinical conditions in order to identify potential hallmarks of inflammation in these patients. An analytical prospective study was conducted using the serum of SCA patients in steady-state (StSt; n = 27) and VOC (n = 22), along with 53 healthy donors (HD). Samples from the VOC group were obtained on admission and on discharge, in the convalescent phase (CV). Levels of chemokines (CXCL8, CXCL10, CL2, CLL3, CCL4, CL5, and CCL11), cytokines (IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-10, IL-12p70, IL-13, IL-17A, TNF-α, and IFN-γ) and growth factors (VEGF, FGFb, PDGF-BB, GM-CSF, and G-CSF) were measured using a Luminex assay, and anaphylatoxins (C3a, C4a, and C5a) were measured using Cytometric Bead Array. SCA patients in StSt showed a pro-inflammatory profile, and were indicated as being higher producers of CCL2, IL-1β, IL-12p70, IFN-γ, IL-17A, and GM-CSF, while VOC is highlighted by molecules IL-4 and IL-5, but also IL-2, IL-7, PDGF-BB, and G-CSF. PDGF-BB and IL-1ra seemed to be two important hallmarks for the acute-to-chronic stage, due to their significant decrease after crisis inflammation and statistical difference in VOC and CV groups. These molecules show higher levels and a strong correlation with other molecules in VOC. Furthermore, they remain at higher levels even after crisis recovery, which suggest their importance in the role of inflammation during crisis and participation in immune cell adhesion and activation. These results support a relevant role of cytokines, neutrophil and monocytes, since these may act as markers of VOC inflammation in SCA patients.
Copyright © 2021 Silva-Junior, Garcia, Cardoso, Dias, Tarragô, Fraiji, Gomes, Amaral, Teixeira-Carvalho, Martins-Filho, De Paula, Costa and Malheiro.

Entities:  

Keywords:  Brazilian Amazon; biomarkers; hemolytic anemia; immune profile; inflammation; molecules

Mesh:

Substances:

Year:  2021        PMID: 33776989      PMCID: PMC7990896          DOI: 10.3389/fimmu.2021.559925

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  42 in total

1.  Monocytes from sickle cell disease patients induce differential pulmonary endothelial gene expression via activation of NF-κB signaling pathway.

Authors:  Surinder Safaya; Martin H Steinberg; Elizabeth S Klings
Journal:  Mol Immunol       Date:  2012-01-20       Impact factor: 4.407

2.  Cytokine profile of sickle cell disease in Oman.

Authors:  Anil Pathare; Salam Al Kindi; Adel Alwan Alnaqdy; Shahina Daar; Huxley Knox-Macaulay; David Dennison
Journal:  Am J Hematol       Date:  2004-12       Impact factor: 10.047

3.  Iron, inflammation, and early death in adults with sickle cell disease.

Authors:  Eduard J van Beers; Yanqin Yang; Nalini Raghavachari; Xin Tian; Darlene T Allen; James S Nichols; Laurel Mendelsohn; Sergei Nekhai; Victor R Gordeuk; James G Taylor; Gregory J Kato
Journal:  Circ Res       Date:  2014-11-06       Impact factor: 17.367

4.  Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.

Authors:  N S Merle; I Boudhabhay; J Leon; V Fremeaux-Bacchi; L T Roumenina
Journal:  Transfus Clin Biol       Date:  2019-02-22       Impact factor: 1.406

5.  Association of homocysteine and inflammatory-related molecules in sickle cell anemia.

Authors:  Wendell Vilas-Boas; Bruno Antonio Veloso Cerqueira; Camylla V B Figueiredo; Rayra Pereira Santiago; Caroline C da Guarda; Thassila Nogueira Pitanga; Sanzio Silva Santana; Angela Maria Dias Zanette; Marilda de Souza Goncalves
Journal:  Hematology       Date:  2015-09-03       Impact factor: 2.269

6.  Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.

Authors:  Bijan Keikhaei; Ali Reza Mohseni; Reza Norouzirad; Mastaneh Alinejadi; Somayeh Ghanbari; Fariba Shiravi; Ghasem Solgi
Journal:  Eur Cytokine Netw       Date:  2013-03       Impact factor: 2.737

7.  Acute chest syndrome in sickle cell anaemia: higher serum levels of interleukin-8 and highly sensitive C-reactive proteins are associated with impaired lung function.

Authors:  Samuel Ademola Adegoke; Bankole Peter Kuti; Kehinde Oluyori Omole; Olufemi Samuel Smith; Oyeku Akibu Oyelami; Oluwagbemiga Oyewole Adeodu
Journal:  Paediatr Int Child Health       Date:  2018-10-08       Impact factor: 1.990

8.  Sickle red cells as danger signals on proinflammatory gene expression, leukotriene B4 and interleukin-1 beta production in peripheral blood mononuclear cell.

Authors:  Thassila N Pitanga; Ricardo R Oliveira; Dalila L Zanette; Caroline C Guarda; Rayra P Santiago; Sanzio S Santana; Valma M L Nascimento; Jonilson B Lima; Graziele Q Carvalho; Vitor V Maffili; Magda O S Carvalho; Luiz C J Alcântara; Valéria M Borges; Marilda S Goncalves
Journal:  Cytokine       Date:  2016-04-02       Impact factor: 3.861

9.  Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.

Authors:  Hao Xu; Nancy J Wandersee; YiHe Guo; Deron W Jones; Sandra L Holzhauer; Madelyn S Hanson; Evans Machogu; David C Brousseau; Neil Hogg; John C Densmore; Sushma Kaul; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

Review 10.  Clinical biomarkers in sickle cell disease.

Authors:  Ghazi A Damanhouri; Jummanah Jarullah; Samy Marouf; S I Hindawi; Gohar Mushtaq; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-09-18       Impact factor: 4.219

View more
  2 in total

1.  Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease.

Authors:  Chiara Moriconi; Monika Dzieciatkowska; Micaela Roy; Angelo D'Alessandro; Philippe Roingeard; June Young Lee; David R Gibb; Maria Tredicine; Marlon A McGill; Annie Qiu; Francesca La Carpia; Richard O Francis; Eldad A Hod; Tiffany Thomas; Martin Picard; Imo J Akpan; Chance John Luckey; James C Zimring; Steven L Spitalnik; Krystalyn E Hudson
Journal:  Br J Haematol       Date:  2022-06-07       Impact factor: 8.615

Review 2.  Moving Toward a Multimodal Analgesic Regimen for Acute Sickle Cell Pain with Non-Opioid Analgesic Adjuncts: A Narrative Review.

Authors:  Martha O Kenney; Wally R Smith
Journal:  J Pain Res       Date:  2022-03-31       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.